165 results on '"Saul, Allan"'
Search Results
2. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM 197 conjugate vaccine
3. Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
4. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
5. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
6. Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli
7. The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants
8. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
9. Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine
10. Simplified low-cost production of O-antigen from Salmonella Typhimurium Generalized Modules for Membrane Antigens (GMMA)
11. Comparison of Colorimetric Assays with Quantitative Amino Acid Analysis for Protein Quantification of Generalized Modules for Membrane Antigens (GMMA)
12. Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
13. Additional file 1 of The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia
14. Efficient autotransporter-mediated extracellular secretion of a heterologous recombinant protein by Escherichia coli
15. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes
16. Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
17. The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city
18. The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia
19. Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
20. Reanalysis of the Pfizer mRNA BNT162b2 SARS-CoV-2 vaccine data fails to find any increased efficacy following the boost: Implications for vaccination policy and our understanding of the mode of action
21. Efficacy, Safety, and Immunogenicity of the Shigella sonnei1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults
22. Impact of Victoria’s Stage 3 lockdown on COVID‐19 case numbers
23. Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
24. GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
25. Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella
26. The use and abuse of a 4-fold increase in antibody response to assess immunogenicity in early stage vaccine clinical trials
27. The Introduction of a Mandatory Mask Policy Was Associated with Significantly Reduced COVID-19 Cases in a Major Metropolitan City
28. Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
29. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.
30. Referee report. For: Tackling human and animal health threats through innovative vaccinology in Africa [version 1; referees: 2 approved]
31. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach
32. Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
33. Prioritizing vaccines for developing world diseases
34. A Recombinant Blood-Stage Malaria Vaccine Reduces Plasmodium falciparum Density and Exerts Selective Pressure on Parasite Populations in a Phase 1-2b Trial in Papua New Guinea
35. Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.
36. Setup of luminescence-based serum bactericidal assay against Salmonella Paratyphi A
37. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
38. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
39. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
40. Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout
41. A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)
42. Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
43. Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection
44. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
45. Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar Recycling
46. Frontispiece: Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
47. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease
48. Sugar–Protein Connectivity Impacts on the Immunogenicity of Site‐Selective Salmonella O‐Antigen Glycoconjugate Vaccines
49. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella
50. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.